A Heterocyclic Strategy for Regulating the Proportion of Type I and Type II of Photodynamic Therapy

Type I photosensitizers (PSs) of photodynamic therapy (PDT) are advanced because they can produce cytotoxic reactive oxygen species (ROS) through electron transfer even in hypoxic environments. However, this process is...